Overview
Poonam Panjwani practices practicing medicine in Mumbai, India.
Ms. Panjwani is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, and Rhabdoid Tumor.
She is actively involved in clinical research, co-authoring 36 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Poonam K. Panjwani
Is Poonam K. Panjwani a top-rated expert for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)?
MediFind is an objective health platform that identifies experts based on real-world data. Poonam K. Panjwani is classified as an Advanced expert for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Poonam K. Panjwani participate in research or clinical trials?
Yes. Poonam K. Panjwani has published 36 articles and abstracts on conditions like Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). You can view a list of Poonam K. Panjwani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Experienced
- Adult Soft Tissue SarcomaMs. Panjwani isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaMs. Panjwani isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Bone TumorMs. Panjwani isExperienced. Learn about Bone Tumor.
- Breast CancerMs. Panjwani isExperienced. Learn about Breast Cancer.
- Breast LumpMs. Panjwani isExperienced. Learn about Breast Lump.
- ChondroblastomaMs. Panjwani isExperienced. Learn about Chondroblastoma.
- ChoriocarcinomaMs. Panjwani isExperienced. Learn about Choriocarcinoma.
- Ewing SarcomaMs. Panjwani isExperienced. Learn about Ewing Sarcoma.
- Fibrocystic Breast DiseaseMs. Panjwani isExperienced. Learn about Fibrocystic Breast Disease.
- FibromatosisMs. Panjwani isExperienced. Learn about Fibromatosis.
- Fibrous DysplasiaMs. Panjwani isExperienced. Learn about Fibrous Dysplasia.
- Germ Cell TumorMs. Panjwani isExperienced. Learn about Germ Cell Tumor.
- Giant Congenital Melanocytic NevusMs. Panjwani isExperienced. Learn about Giant Congenital Melanocytic Nevus.
- Gliomatosis CerebriMs. Panjwani isExperienced. Learn about Gliomatosis Cerebri.
- HemangioendotheliomaMs. Panjwani isExperienced. Learn about Hemangioendothelioma.
- Hepatic HemangiomaMs. Panjwani isExperienced. Learn about Hepatic Hemangioma.
- Hodgkin LymphomaMs. Panjwani isExperienced. Learn about Hodgkin Lymphoma.
- Inflammatory Myofibroblastic TumorMs. Panjwani isExperienced. Learn about Inflammatory Myofibroblastic Tumor.
- Mediastinal TumorMs. Panjwani isExperienced. Learn about Mediastinal Tumor.
- NecrosisMs. Panjwani isExperienced. Learn about Necrosis.
- Osteitis FibrosaMs. Panjwani isExperienced. Learn about Osteitis Fibrosa.
- OsteosarcomaMs. Panjwani isExperienced. Learn about Osteosarcoma.
- RetinoblastomaMs. Panjwani isExperienced. Learn about Retinoblastoma.
- Rhabdoid TumorMs. Panjwani isExperienced. Learn about Rhabdoid Tumor.
- RhabdomyosarcomaMs. Panjwani isExperienced. Learn about Rhabdomyosarcoma.